The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030..

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

A detailed review of the overall landscape of fragment-based drug discovery library and service providers.

Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).

An analysis of the partnerships that have been established in the recent past.

A detailed analysis on acquisition targets.

An insightful competitiveness analysis of fragment-based drug discovery library and service providers.

An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Technique

X-ray Crystallography

Nuclear Magnetic Resonance

Surface Plasmon Resonance

Other Screening Techniques

  • Type of Service

Library Screening

Fragment Screening

Fragment Optimization

  • End User

Industry Players

Non-Industry Players

  • Key Geographical Region

North America (US and Canada)

Europe (UK, France, Germany, Spain, Italy, and rest of Europe)

Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)


Key companies covered in the report:
  • 2bind
  • Charles River Laboratories
  • ChemAxon
  • ComInnex
  • Creative Biolabs
  • Creative Biostructure
  • CRELUX
  • Domainex
  • Evotec
  • Red Glead Discovery
Press Release: Variation 1 (Format 2)
  • SARomics Biostructures
  • Shanghai ChemPartner
  • Sygnature Discovery
  • Vernalis Research


For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
Other recent offerings

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
929 Posts

Made with by Mamby